XWEL — XWELL Share Price
- $7.53m
- -$3.38m
- $30.11m
- 37
- 69
- 35
- 44
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | n/a | ||
PEG Ratio (f) | n/a | ||
EPS Growth (f) | n/a | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 0.66 | ||
Price to Tang. Book | 0.89 | ||
Price to Free Cashflow | n/a | ||
Price to Sales | 0.22 | ||
EV to EBITDA | n/a |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | -85.89% | ||
Return on Equity | -108.94% | ||
Operating Margin | -76.47% |
Financial Summary
Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | $m | 48.52 | 8.38 | 73.73 | 55.94 | 30.11 | 36.23 | n/a | -9.68% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
XWELL, Inc. is a global health and wellness holding company. The Company operates through four segments: XpresTest, XpresSpa, Treat, and Naples Wax Center. The XpresTest segment provides diagnostic COVID-19 tests at XpresCheck Wellness Centers in airports, to airport employees and to the traveling public but has transitioned to the centers for disease control and prevention (CDC’s) bio-surveillance program. XpresTest’s HyperPointe business provides a range of service and support options for its customers, including technical support services and advanced services. The XpresSpa segment provides travelers premium spa services, including massage, nail and skin care, as well as spa and travel products. Treat segment is a wellness brand that provides access to wellness services for travelers at on-site centers. Naples Wax Center segment operates three high-performing locations with core products and service offerings from face and body waxing to a range of skincare and cosmetic products.
Directors
- Bruce Bernstein NEC (57)
- Scott Milford PRE (57)
- James Berry CFO (64)
- David Kohel CTO
- Michael Lebowitz IND (49)
- Donald Stout IND (75)
- Robert Weinstein IND (61)
- Last Annual
- December 31st, 2023
- Last Interim
- March 31st, 2024
- Incorporated
- January 9th, 2006
- Public Since
- June 18th, 2010
- No. of Shareholders
- 86
- No. of Employees
- 266
- Sector
- Personal & Household Products & Services
- Industry
- Consumer Defensives
- Exchange
NASDAQ Capital Market
- Shares in Issue
- 4,183,435
![Blurred out image of a map](https://www.stockopedia.com/assets/conversion/images/maps_placeholder.jpg)
- Address
- 254 WEST 31ST STREET, 11TH FLOOR, NEW YORK, 10001
- Web
- https://www.xwell.com/
- Phone
- +1 2127509595
- Auditors
- Marcum LLP
Upcoming Events for XWEL
XWELL Inc Annual Shareholders Meeting
Q3 2024 XWELL Inc Earnings Release
Similar to XWEL
Beauty Health Co
NASDAQ Capital Market
China Liberal Education Holdings
NASDAQ Capital Market
Color Star Technology Co
NASDAQ Capital Market
E-Home Household Service Holdings
NASDAQ Capital Market
EpicQuest Education International
NASDAQ Capital Market
FAQ
As of Today at 24:14 UTC, shares in XWELL are trading at $1.68. This share price information is delayed by 15 minutes.
Shares in XWELL last closed at $1.68 and the price had moved by -64.68% over the past 365 days. In terms of relative price strength the XWELL share price has underperformed the S&P500 Index by -71.89% over the past year.
The overall consensus recommendation for XWELL is Buy. You can view the full broker recommendation list by unlocking its StockReport.
XWELL does not currently pay a dividend.
XWELL does not currently pay a dividend.
XWELL does not currently pay a dividend.
To buy shares in XWELL you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $1.68, shares in XWELL had a market capitalisation of $7.03m.
Here are the trading details for XWELL:
- Country of listing: United States
- Exchange: NAQ
- Ticker Symbol: XWEL
Based on an overall assessment of its quality, value and momentum XWELL is currently classified as a Value Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in XWELL is $7.00. That is 316.67% above the last closing price of $1.68.
Analysts covering XWELL currently have a consensus Earnings Per Share (EPS) forecast of -$2.63 for the next financial year.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like XWELL. Over the past six months, its share price has underperformed the S&P500 Index by -16.12%.
As of the last closing price of $1.68, shares in XWELL were trading -13.24% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The XWELL PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $1.68.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
XWELL's management team is headed by:
- Bruce Bernstein - NEC
- Scott Milford - PRE
- James Berry - CFO
- David Kohel - CTO
- Michael Lebowitz - IND
- Donald Stout - IND
- Robert Weinstein - IND